17 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Sesen Bio, Inc. SESN stock increased by 22.7% to $1.35 during Wednesday's pre-market session. The market value of their outstanding shares is at $118.4 million.
• Agile Therapeutics, Inc. AGRX stock surged 20.8% to $2.90. The market cap seems to be at $70.2 million.
• ReWalk Robotics, Inc. RWLK stock surged 9.4% to $2.90. The market value of their outstanding shares is at $22.3 million.
• Adamis Pharmaceuticals, Inc. ADMP shares surged 6.6% to $0.81. The market cap stands at $49.7 million.
• SELLAS Life Sciences, Inc. SLS shares surged 3.4% to $0.21. The market value of their outstanding shares is at $28.6 million.
• CVS Health, Inc. CVS shares increased by 2.6% to $69.11. The market value of their outstanding shares is at $82.0 billion. According to the most recent rating by RBC Capital, on September 27, the current rating is at Outperform.
• Grifols, Inc. GRFS shares surged 1.5% to $21.82. According to the most recent rating by Santander, on October 28, the current rating is at Buy.
• Qiagen, Inc. QGEN stock surged 1.4% to $30.74. The market value of their outstanding shares is at $6.7 billion. According to the most recent rating by Kepler Cheuvreux, on October 09, the current rating is at Reduce.
• Teva Pharmaceutical Indus, Inc. TEVA shares moved upwards by 1.3% to $8.64. According to the most recent rating by Gabelli & Co., on October 17, the current rating is at Buy.

Losers

• Supernus Pharmaceuticals, Inc. SUPN stock decreased by 27.6% to $21.10 during Wednesday's pre-market session. The market cap seems to be at $1.4 billion. According to the most recent rating by Jefferies, on November 06, the current rating is at Hold.
• Amneal Pharmaceuticals, Inc. AMRX stock decreased by 27.2% to $2.50. The market cap stands at $920.3 million. The most recent rating by Guggenheim, on September 12, is at Sell, with a price target of $2.50.
• GW Pharmaceuticals, Inc. GWPH shares plummeted 13.2% to $117.00. The market value of their outstanding shares is at $3.5 billion. The most recent rating by Cantor Fitzgerald, on November 06, is at Overweight, with a price target of $174.00.
• Eloxx Pharmaceuticals, Inc. ELOX stock fell 5.0% to $6.22. The market value of their outstanding shares is at $243.2 million. According to the most recent rating by Janney Capital, on September 06, the current rating is at Buy.
• OPKO Health, Inc. OPK stock declined 4.5% to $1.49. The market cap seems to be at $945.1 million.
• Mallinckrodt, Inc. MNK shares decreased by 3.2% to $3.22. The market cap stands at $202.4 million. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
• NextCure, Inc. NXTC shares decreased by 2.4% to $90.00. The market value of their outstanding shares is at $868.1 million. The most recent rating by Bank of America, on September 09, is at Buy, with a price target of $44.00.
• Advaxis, Inc. ADXS shares fell 1.3% to $0.32. The market cap stands at $6.1 million.